Discover
STOK
Stoke Therapeutics, Inc.
24.37
1 x 24.19
2 x 29.44
bid
ask
-
0.95
3.75%
2 @ 04:00 PM
24.72 +0.35 (1.44%)
| Ytd | -23.22% | |
| 1y | -9.10% |
23.35
day range
25.58
20.32
52 week range
40.22
| Open | 25.58 | Prev Close | 25.32 | Low | 23.35 | High | 25.58 | Mkt Cap | 1.57B |
| Vol | 1.17M | Avg Vol | 852.96K | EPS | -3.38 | P/E | N/A | Forward P/E | -6.93 |
| Beta | 1.26 | Short Ratio | 13.74 | Inst. Own | 125.32% | Dividend | N/A | Div Yield | N/A |
| Ex Div Date | N/A | Earning | 11-03 | 50-d Avg | 29.82 | 200-d Avg | 31.61 | 1yr Est | 46.46 |
STOK News
businesswire.com
Stoke Therapeutics Announces Presentations of STK-002, an Investigational Medicine for the Treatment
BEDFORD, Mass.--(BUSINESS WIRE)--Stoke Therapeutics, Inc. (Nasdaq: STOK), a biotechnology company de
gurufocus.com
Stoke Therapeutics Announces Completion of Successful Meeting with the FDA to Align on Planned U.S.
Stoke Therapeutics, Inc. (Nasdaq: STOK) is a biotechnology company dedicated to restoring protein ex
businesswire.com
Stoke Therapeutics Announces Completion of Successful Meeting with the FDA to Align on Planned U.S.
BEDFORD, Mass.--(BUSINESS WIRE)--Stoke Therapeutics, Inc. (Nasdaq: STOK) is a biotechnology company